Dov Gavish

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

Donald S. Silverberg, Dov Wexler, Miriam Blum et al. · Journal of the American College of Cardiology · 2000 · 730 citations

Medicine, Cardiology, Pharmacotherapy +14

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

Gerhard M. Kostner, Dov Gavish, Beate Leopold et al. · Circulation · 1989 · 341 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

S Eisenberg, Dov Gavish, Y Oschry et al. · Journal of Clinical Investigation · 1984 · 295 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +17

Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

Dov Gavish, Neal Azrolan, J L Breslow · Journal of Clinical Investigation · 1989 · 156 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12